HALE DAVID F sold 35.9% of their position (445.00 shares) of BIOCEPT INC on the open market
Open‑market sale worth $1.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/10/2021ACC: 0001209191-21-069092
-445.00
Net shares
Net seller
$1.8K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
445.00 disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−363.00
Price / share
$4.06
Trade value
$1.47K
% of position
10.4%
12/9/2021
3.48K→3.11K
Common Stock
Indirect
Shares
−11.00
Price / share
$4.07
Trade value
$44.79
% of position
9.8%
12/9/2021
112.00→101.00
Common Stock
Direct
Shares
−71.00
Price / share
$4.07
Trade value
$288.71
% of position
8.2%
12/9/2021
867.00→796.00
Total
Net shares
−445.00
Net value
-$1.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/9/2021 | S · Sale | −363.00 | $4.06 | $1.47K | 10.4% | 3.48K | 3.11K |
| Common Stock Indirect | 12/9/2021 | S · Sale | −11.00 | $4.07 | $44.79 | 9.8% | 112.00 | 101.00 |
| Common Stock Direct | 12/9/2021 | S · Sale | −71.00 | $4.07 | $288.71 | 8.2% | 867.00 | 796.00 |
| Total | −445.00 | -$1.81K | ||||||
Derivative Transactions0
No derivative transactions reported